retatrutide glp-1 gip glucagon agonist vs Tirzepatide Compared Medscape | The investigational triple

Pregnancy increases your body fat stores deliberately

GLP-1s may not be suitable for people who: Have a history of pancreatitis Have certain thyroid conditions (e.g., medullary thyroid cancer) Are pregnant or breastfeeding (depending on the specific medication) Have severe gastrointestinal conditions, like gastroparesis GLP-1 receptor agonists, including Tirzepatide, have been shown to lead to significant weight loss, with many people losing 10-15% of their body weight over time

Muscle Loss During Treatment Was Not Prevented Rapid weight loss from any method including GLP-1 can result in loss of lean muscle mass alongside fat

Compounding allows PlexusDx to deliver treatment rapidly across all 50 states without insurance requirements or membership fees